New study tracks BRIUMVI safety in pregnancy for MS patients
NCT ID NCT06433765
First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 31 times
Summary
This study observes pregnant women with multiple sclerosis to compare the rate of major birth defects between those who took BRIUMVI and those who did not. About 728 participants will provide data during and after pregnancy. The goal is to gather safety information, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BRIUMVI® Pregnancy Registry Virtual Research Coordination Center
RECRUITINGWilmington, North Carolina, 28401-3331, United States
Conditions
Explore the condition pages connected to this study.